Search Results 271-280 of 17273 for egfr

1. Estrogen receptor mRNA directed therapy for triple negative breast cancer

   Some targeted therapies have been evaluated, including anti-angiogenic agents (e.g. bevacizumab, sunitinib, sorafenib) and. EGFR inhibitors (e.g. cetuximab), ...

2. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND) - Mayo Clinic

   CKD stage: Kidney Disease Outcomes Quality Initiative (KDOQI) CKD stages 3, 4, or 5 defined by electronic estimated glomerular filtration rate (eGFR) using the ...

3. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) - Mayo Clinic

   - Known actionable mutation/gene rearrangement of EGFR (except for Cohort C), ALK, ROS1, RET, NTRK, KRAS, and BRAF. - Unstable angina or myocardial ...

4. LUPKYNIS US Registry Trial - Mayo Clinic

   serum creatinine and/or eGFR;; Have access to US healthcare insurance;; Ability to understand and provide written informed consent. Exclusion Criteria: Off ...

5. Study To Evaluate The Effectiveness And Safety Of Remdesivir In Participants With Severely Reduced Kidney Function Who Are Hospitalized For Coronavirus Disease 2019 - Mayo Clinic

   Severely reduced kidney function (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73m^2 ), using the Chronic Kidney Disease Epidemiology ...

6. Denosumab Stimulated Parathyroid Scan Pilot Study in Persistent or Recurrent Primary Hyperparathyroidism - Mayo Clinic

   Renal insufficiency as defined by serum creatinine > 2.0 mg/dL or eGFR < 30 ml/minute. Patients with primary hyperparathyroidism not eligible for surgery ...

7. Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients - Mayo Clinic

   - Estimated eGFR > 30 ml/min by MDRD. Histologic Criteria for Eligibility: - ABMR: microvascular inflammation scores for glomerulitis (g) and peritubular

8. Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) - Mayo Clinic

   eGFR ≥ 45 for children and adults; Concomitant use of angiotensin-converting-enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) at stable doses ...

9. Assessment of Vertebral Fracture Risk using VFA and Vertebral Strength Assessment with DXA-Finite Element Analysis in Liver Transplant Recipients in Pre-transplant Period - Mayo Clinic

   First time liver transplant candidates deemed too early for liver transplant. 24 hour urine Creatinine clearance of > 40 mg/dl and/or eGFR > 60; however bone ...

10. Laryngeal Clinical Trials - Mayo Clinic Research

    The purpose of this study is to demonstrate the safety and tolerability of JAB-3312 in combination with anti-PD-1 mAb or MEKi or KRASi or EGFR-TKI in patients ...